Medical Institutions Can Now Charge Cancellation Fees from June, Potentially Mitigating Nearly ¥10 Million Annual Deficit; Challenges Remain for Implementation – au Web Portal

News Highlights

Starting June 2026, medical institutions will be able to charge cancellation fees for no-shows. With reports of some institutions facing annual deficits of nearly ¥10 million due to no-shows, this is anticipated as a measure to improve management. However, implementation presents numerous challenges, including patient communication and system adjustments. This development underscores the importance of improving revenue structures and operational efficiency in healthcare facilities.

M&A Medical Editorial Perspective

The authorization to charge no-show fees shines a light on one of the revenue pressures faced by medical institutions. An annual deficit of nearly ¥10 million is an unignorable loss, particularly for small to medium-sized clinics and specialized hospitals. Historically, collecting cancellation fees has been avoided due to the “difficulty in explaining to patients” and the “risk of damaging relationships.” However, this regulatory change supports medical institutions in exercising their legitimate right to protect their management resources. From an M&A standpoint, reducing such “hidden costs” suggests the potential to enhance business profitability, leading to more favorable terms for succession or sale. For instance, if cancellation fee revenue can be secured stably, it could improve operating profit margins, making it easier for potential buyers to offer higher valuations. This is not merely about cost reduction but directly relates to enhancing the enterprise value of medical institutions.

Key Discussion Points from This News

• The annual deficit of nearly ¥10 million due to no-shows highlights the significant hidden costs in healthcare management.
• The authorization to charge cancellation fees offers medical institutions a new option for improving revenue management and operational performance.
• The necessity of incorporating cancellation fee collection into management strategy, while considering patient relationships, has increased.
• Improvements in revenue structure have the potential to directly contribute to the enhancement of enterprise value in M&A transactions involving medical institutions.

Practical Questions Arising from This News

• What are the specific procedures for collecting cancellation fees, and what amounts are considered reasonable?
• How can patients who frequently no-show be communicated with to gain understanding and prevent relationship deterioration?
• How can cancellation fee revenue be evaluated and included in valuations during M&A?

“Should I Consult Too?” If You Feel This Way

If losses from no-shows are impacting your business operations, or if you are considering charging cancellation fees as a future revenue improvement measure, we recommend consulting with specialists first. M&A advisory firms can quantitatively analyze the revenue improvement effects of collecting cancellation fees and estimate how this will impact the enterprise value during business succession or sale. Identifying management challenges early and finding the optimal solution, including the option of M&A, leads to business continuation or sale under better terms.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics with a full success-fee basis, as a certified M&A support institution by the Small and Medium Enterprise Agency. Consultations are handled with strict confidentiality. Free consultation here